Understanding molecular mechanisms and miRNA-based targets in diabetes foot ulcers
- PMID: 38183502
- DOI: 10.1007/s11033-023-09074-0
Understanding molecular mechanisms and miRNA-based targets in diabetes foot ulcers
Abstract
In today's culture, obesity and overweight are serious issues that have an impact on how quickly diabetes develops and how it causes complications. For the development of more effective therapies, it is crucial to understand the molecular mechanisms underlying the chronic problems of diabetes. The most prominent effects of diabetes are microvascular abnormalities such as retinopathy, nephropathy, and neuropathy, especially diabetes foot ulcers, as well as macrovascular abnormalities such as heart disease and atherosclerosis. MicroRNAs (miRNAs), which are highly conserved endogenous short non-coding RNA molecules, have been implicated in several physiological functions recently, including the earliest stages of the disease. By binding to particular messenger RNAs (mRNAs), which cause mRNA degradation, translation inhibition, or even gene activation, it primarily regulates posttranscriptional gene expression. These molecules exhibit considerable potential as diagnostic biomarkers for disease and are interesting treatment targets. This review will provide an overview of the latest findings on the key functions that miRNAs role in diabetes and its complications, with an emphasis on the various stages of diabetic wound healing.
Keywords: Diabetes foot ulcers; Diabetes wound healing; Neuropathy; Obesity; microRNAs (miRNAs).
© 2023. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
The Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound Healing.Genes (Basel). 2014 Sep 29;5(4):926-56. doi: 10.3390/genes5040926. Genes (Basel). 2014. PMID: 25268390 Free PMC article. Review.
-
The role of microRNAs in the healing of diabetic ulcers.Int Wound J. 2019 Jun;16(3):621-633. doi: 10.1111/iwj.13070. Epub 2019 Feb 28. Int Wound J. 2019. PMID: 30821119 Free PMC article. Review.
-
Role of microRNAs in diabetic foot ulcers: Mechanisms and possible interventions.Diabetes Res Clin Pract. 2024 Nov;217:111858. doi: 10.1016/j.diabres.2024.111858. Epub 2024 Sep 14. Diabetes Res Clin Pract. 2024. PMID: 39284457 Review.
-
Non-coding RNAs in diabetic foot ulcer- a focus on infected wounds.Diabetes Metab Res Rev. 2024 Mar;40(3):e3740. doi: 10.1002/dmrr.3740. Epub 2023 Oct 15. Diabetes Metab Res Rev. 2024. PMID: 37839046 Review.
-
Angio-microRNAs in diabetic foot ulcer-: Mechanistic insights and clinical perspectives.Prog Biophys Mol Biol. 2024 Oct;192:1-10. doi: 10.1016/j.pbiomolbio.2024.07.006. Epub 2024 Jul 27. Prog Biophys Mol Biol. 2024. PMID: 39069213 Review.
Cited by
-
MicroRNA-122-5p is upregulated in diabetic foot ulcers and decelerates the transition from the inflammatory to the proliferative stage.World J Diabetes. 2025 Apr 15;16(4):100113. doi: 10.4239/wjd.v16.i4.100113. World J Diabetes. 2025. PMID: 40236859 Free PMC article.
-
The emerging modulators of non-coding RNAs in diabetic wound healing.Front Endocrinol (Lausanne). 2024 Oct 8;15:1465975. doi: 10.3389/fendo.2024.1465975. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39439564 Free PMC article. Review.
-
Peptides based on the interface of hnRNPA2B1-transthyretin complex repress retinal angiogenesis in diabetic retinopathy.J Transl Med. 2025 Apr 19;23(1):458. doi: 10.1186/s12967-025-06437-y. J Transl Med. 2025. PMID: 40253339 Free PMC article.
References
-
- Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW et al (2018) IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 138:271–281 - PubMed
-
- Nellaiappan K, Preeti K, Khatri DK, Singh SB (2022) Diabetic complications: an update on pathobiology and therapeutic strategies. Current diabetes reviews. 18(1):31-44
-
- Bhoomika, Sherkhane Gundu, Chayanika Anika, Sood Dharmendra Kumar, Khatri Shashi Bala, Singh (2021) Mitochondrial remodelling—a vicious cycle in diabetic complications Molecular Biology Reports 48(5):4721–4731 https://doi.org/10.1007/s11033-021-06408-8
-
- Donnelly R, Emslie-Smith AM, Gardner ID, Morris AD (2000) ABC of arterial and venous disease: vascular complications of diabetes. BMJ (Clinical Research ed) 320(7241):1062–1066 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical